Results 41 to 50 of about 84,586,414 (211)

The effect of 5-HT2a/2c receptor agonist microinjected into central amygdaloid nucleus and median preoptic area on maternal aggressive behavior in rats Efeito sobre o comportamento materno agressivo de ratos da microinjeção do agonista seletivo de receptores 5-HT2a/2c no núcleo central da amígdala e na área pré-óptica medial

open access: yesBrazilian Journal of Psychiatry, 2006
OBJECTIVE: Much evidence supports the hypothesis that 5-hydroxytryptamine (5-HT) activation is related to the inhibition of aggression. We examined potentially pro- and anti-aggressive effects of the 5-HT2A/2C receptor agonist on specific brain sites ...
Rosa Maria Martins de Almeida   +4 more
doaj   +1 more source

Pharmacokinetics and safety of a modified‐release psilocybin formulation: A SAD Phase I trial in normal‐weight and overweight/obese participants

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to evaluate the safety, tolerability and pharmacokinetics of a novel oral modified‐release psilocybin formulation (REL‐P11) in normal‐weight and overweight/obese healthy adults and to assess its suitability for controlled, subperceptual exposure, in light of emerging evidence supporting serotonergic modulation in metabolic ...
Anna Signor   +11 more
wiley   +1 more source

The therapeutic role of 5-HT1A and 5-HT2A receptors in depression [PDF]

open access: yes, 2004
Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC446220/[EN]The selective serotonin reuptake inhibitors (SSRIs) are the most frequently prescribed antidepressant drugs, because they are well tolerated and have no severe side effects.
Adell, Albert   +4 more
core  

Increased DOI-Induced Wet-Dog Shakes in Adrenocorticotropic Hormone–Treated Rats Are Not Affected by Chronic Imipramine Treatment: Possible Involvement of Enhanced 5-HT2A–Receptor Expression in the Frontal Cortex

open access: yesJournal of Pharmacological Sciences, 2008
We examined the influence of imipramine, a traditional tricyclic antidepressant, on the binding to serotonin (5-HT)2receptors and levels of 5-HT2A–receptor mRNA in the frontal cortex of rats treated with adrenocorticotropic hormone (ACTH).
Yoshihisa Kitamura   +11 more
doaj   +1 more source

Expression of serotonin 1A and 2A receptors in molecular- and projection-defined neurons of the mouse insular cortex

open access: yesMolecular Brain, 2020
The serotonin (5-HT) system is the target of multiple anxiolytics, including Buspirone, which is a partial agonist of the serotonin 1A receptor (5-HT1A). Similarly, ligands of the serotonin 2A receptor (5-HT2A) were shown to alter anxiety level.
Anes Ju   +4 more
doaj   +1 more source

Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats

open access: yesFrontiers in Neuroscience, 2023
IntroductionPsilocybin is one of the most extensively studied psychedelic drugs with a broad therapeutic potential. Despite the fact that its psychoactivity is mainly attributed to the agonism at 5-HT2A receptors, it has high binding affinity also to 5 ...
Filip Tylš   +20 more
doaj   +1 more source

Antiseizure potency and neurotoxicity of the enantiomers of fenfluramine and norfenfluramine in rats and correlations with their concentrations in plasma and brain

open access: yesEpilepsia, EarlyView.
Abstract Objective Based on the evidence that fenfluramine‐induced anorexia, weight loss, and cardiovascular toxicity are primarily mediated by the d‐enantiomers of fenfluramine and its metabolite norfenfluramine, we investigated pharmacokinetic/pharmacodynamic correlations for the active enantiomers of fenfluramine and norfenfluramine in the rat ...
Yara Sheeni   +4 more
wiley   +1 more source

Growing Evidence for Heterogeneous Synaptic Localization of 5-HT2A Receptors

open access: yes, 2017
International audienceThe serotonin 2A (5-HT2A) receptor subtype continues to attract attention as a target for numerous psychoactive drugs including psychedelic hallucinogens, antidepressants, anxiolytics, and atypical antipsychotics.
Becamel, Carine   +7 more
core   +1 more source

Structure-based identification of aporphines with selective 5-HT2A receptor-binding activity

open access: yes, 2013
Selective blockade of the serotonin 5-HT2A receptor is a useful therapeutic approach for a number of disorders, including schizophrenia, insomnia and ischaemic heart disease.
Chung, L.Y.   +4 more
core   +3 more sources

A non-hallucinogenic LSD analog with therapeutic potential for mood disorders

open access: yesCell Reports, 2023
Summary: Hallucinations limit widespread therapeutic use of psychedelics as rapidly acting antidepressants. Here we profiled the non-hallucinogenic lysergic acid diethylamide (LSD) analog 2-bromo-LSD (2-Br-LSD) at more than 33 aminergic G protein-coupled
Vern Lewis   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy